Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection A

CARA: Cara Therapeutics, Inc.
2022-01-10 08:00:00
Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection Achieves Positive Topline Results in Phase 3 Clinical Study in Japan for the Treatment of Pruritus in Hemodialysis Patients